← Every company

Axsome Therapeutics Inc SEC Filings

What Axsome Therapeutics Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

AXSM overview →
Filings on file
124
since Nov 10, 2016
Warning signs
1
latest Jun 26, 2023
Last results
Aug 10, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Aug 10, 2026
Quarterly report
10-Q
Read ↗
Aug 10, 2026
Results announced
8-K
Read ↗
Jun 9, 2026
Executive or director change
8-K
Read ↗
Jun 9, 2026
Shareholder vote
8-K
Read ↗
May 4, 2026
Quarterly report
10-Q
Read ↗
May 4, 2026
Results announced
8-K
Read ↗
Feb 23, 2026
Annual report
10-K
Read ↗
Feb 23, 2026
Results announced
8-K
Read ↗
Jan 12, 2026
Results announced
8-K
Read ↗
Nov 3, 2025
Quarterly report
10-Q
Read ↗
Nov 3, 2025
Results announced
8-K
Read ↗
Aug 4, 2025
Quarterly report
10-Q
Read ↗
Aug 4, 2025
Results announced
8-K
Read ↗
Jun 9, 2025
Shareholder vote
8-K
Read ↗
May 13, 2025
Material agreementNew debtUnregistered share sale
8-K
Read ↗
May 5, 2025
Quarterly report
10-Q
Read ↗
May 5, 2025
Results announced
8-K
Read ↗
Feb 18, 2025
Annual report
10-K
Read ↗
Feb 18, 2025
Results announced
8-K
Read ↗
Jan 13, 2025
Results announced
8-K
Read ↗
Nov 12, 2024
Quarterly report
10-Q
Read ↗
Nov 12, 2024
Results announced
8-K
Read ↗
Oct 1, 2024
Material agreement
8-K
Read ↗
Aug 5, 2024
Quarterly report
10-Q
Read ↗
Aug 5, 2024
Results announced
8-K
Read ↗
Jun 11, 2024
Shareholder vote
8-K
Read ↗
May 6, 2024
Quarterly report
10-Q
Read ↗
May 6, 2024
Results announced
8-K
Read ↗
Feb 23, 2024
Annual report
10-K
Read ↗
Feb 20, 2024
Results announced
8-K
Read ↗
Jan 4, 2024
Results announced
8-K
Read ↗
Nov 6, 2023
Quarterly report
10-Q
Read ↗
Nov 6, 2023
Results announced
8-K
Read ↗
Oct 11, 2023
Executive or director change
8-K
Read ↗
Aug 7, 2023
Quarterly report
10-Q
Read ↗
Aug 7, 2023
Results announced
8-K
Read ↗
Jun 26, 2023
Auditor change
8-K
Read ↗
Jun 8, 2023
Executive or director changeShareholder vote
8-K
Read ↗
May 9, 2023
Quarterly report
10-Q
Read ↗
May 8, 2023
Results announced
8-K
Read ↗
Feb 28, 2023
Annual report
10-K
Read ↗
Feb 27, 2023
Results announced
8-K
Read ↗
Feb 22, 2023
Material agreement
8-K
Read ↗
Jan 9, 2023
Material agreement
8-K
Read ↗
Nov 14, 2022
Acquisition or sale completed
8-K
Read ↗
Nov 7, 2022
Quarterly report
10-Q
Read ↗
Nov 7, 2022
Results announced
8-K
Read ↗
Aug 23, 2022
Results announced
8-K
Read ↗
Aug 9, 2022
Quarterly report
10-Q
Read ↗
Jun 7, 2022
Shareholder vote
8-K
Read ↗
May 9, 2022
Acquisition or sale completedNew debtUnregistered share sale
8-K
Read ↗
May 2, 2022
Quarterly report
10-Q
Read ↗
May 2, 2022
Results announced
8-K
Read ↗
Mar 31, 2022
Material agreement
8-K/A
Read ↗
Mar 28, 2022
Material agreement
8-K
Read ↗
Mar 1, 2022
Material agreement
8-K
Read ↗
Mar 1, 2022
Annual report
10-K
Read ↗
Mar 1, 2022
Results announced
8-K
Read ↗
Nov 8, 2021
Quarterly report
10-Q
Read ↗
Nov 8, 2021
Results announced
8-K
Read ↗
Oct 18, 2021
Material agreement
8-K
Read ↗
Aug 9, 2021
Quarterly report
10-Q
Read ↗
Aug 9, 2021
Results announced
8-K
Read ↗
Jun 8, 2021
Shareholder vote
8-K
Read ↗
May 10, 2021
Quarterly report
10-Q
Read ↗
May 10, 2021
Results announced
8-K
Read ↗
Mar 1, 2021
Annual report
10-K
Read ↗
Mar 1, 2021
Results announced
8-K
Read ↗
Nov 6, 2020
Quarterly report
10-Q/A
Read ↗
Nov 5, 2020
Quarterly report
10-Q
Read ↗
Nov 5, 2020
Results announced
8-K
Read ↗
Sep 29, 2020
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Sep 8, 2020
Executive or director change
8-K
Read ↗
Aug 10, 2020
Quarterly report
10-Q
Read ↗
Aug 10, 2020
Results announced
8-K
Read ↗
Jun 8, 2020
Executive or director changeShareholder vote
8-K
Read ↗
May 11, 2020
Quarterly report
10-Q
Read ↗
May 8, 2020
Results announced
8-K
Read ↗
Apr 21, 2020
Executive or director change
8-K
Read ↗
Mar 12, 2020
Annual report
10-K
Read ↗
Mar 12, 2020
Results announced
8-K
Read ↗
Mar 5, 2020
Executive or director change
8-K
Read ↗
Jan 13, 2020
Material agreementUnregistered share sale
8-K
Read ↗
Dec 5, 2019
Material agreement
8-K
Read ↗
Nov 7, 2019
Quarterly report
10-Q
Read ↗
Nov 7, 2019
Results announced
8-K
Read ↗
Aug 8, 2019
Quarterly report
10-Q
Read ↗
Aug 8, 2019
Results announced
8-K
Read ↗
Jul 29, 2019
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Jun 7, 2019
Shareholder vote
8-K
Read ↗
May 9, 2019
Material agreement
8-K
Read ↗
May 9, 2019
Quarterly report
10-Q
Read ↗
May 9, 2019
Results announced
8-K
Read ↗
Mar 15, 2019
Annual report
10-K
Read ↗
Mar 14, 2019
Results announced
8-K
Read ↗
Mar 6, 2019
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Nov 27, 2018
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Nov 9, 2018
Quarterly report
10-Q
Read ↗
Nov 9, 2018
Results announced
8-K
Read ↗
Sep 28, 2018
Material agreement
8-K
Read ↗
Aug 8, 2018
Quarterly report
10-Q
Read ↗
Aug 8, 2018
Results announced
8-K
Read ↗
Jun 5, 2018
Shareholder vote
8-K
Read ↗
May 8, 2018
Quarterly report
10-Q
Read ↗
May 8, 2018
Results announced
8-K
Read ↗
Apr 19, 2018
Executive or director change
8-K
Read ↗
Mar 7, 2018
Annual report
10-K
Read ↗
Mar 7, 2018
Results announced
8-K
Read ↗
Dec 4, 2017
Material agreement
8-K
Read ↗
Nov 8, 2017
Results announced
8-K
Read ↗
Nov 8, 2017
Quarterly report
10-Q
Read ↗
Oct 20, 2017
Material agreement
8-K
Read ↗
Aug 9, 2017
Quarterly report
10-Q
Read ↗
Aug 9, 2017
Results announced
8-K
Read ↗
Jul 7, 2017
Executive or director change
8-K
Read ↗
Jun 19, 2017
Executive or director change
8-K
Read ↗
Jun 2, 2017
Shareholder vote
8-K
Read ↗
May 9, 2017
Quarterly report
10-Q
Read ↗
May 9, 2017
Results announced
8-K
Read ↗
Mar 7, 2017
Results announced
8-K
Read ↗
Mar 7, 2017
Annual report
10-K
Read ↗
Nov 14, 2016
Results announced
8-K
Read ↗
Nov 14, 2016
Quarterly report
10-Q
Read ↗
Nov 10, 2016
Material agreementNew debtUnregistered share sale
8-K
Read ↗

Source: Axsome Therapeutics Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on AXSM

Related datasets